LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 22nd Prioritisation – 1st quarter 2015

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 22nd Prioritisation – 1st quarter 2015. HSO: 22nd Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
81Kb
Abstract

For the 22nd prioritisation (April 2015), 10 were filtered out of 180 identified drugs and were sent to prioritisation. Of these, 4 drugs were ranked as "highly relevant" by the expert panel, 4 as "relevant" and 2 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 22nd Prioritisation
Deposited on:13 May 2015 13:00
Last Modified:23 Aug 2017 12:40

Repository Staff Only: item control page